Weight loss injections like semaglutide and tirzepatide are getting a lot of attention right now. They work for a lot of people. But they are not for everyone, and using them when you should not can cause serious harm.
This is a straight answer to who should not use weight loss injections, backed by clinical data and medical guidelines. qualified health professional
What Are Weight Loss Injections?
The most common weight loss injections right now are GLP-1 receptor agonists. Semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro) are the main ones. They work by slowing digestion, reducing appetite, and helping regulate blood sugar.
Clinical trials show semaglutide produces around 15% body weight reduction over 68 weeks. Tirzepatide shows up to 22% in some trials. Those are real numbers. But the drug does not care about your other health conditions. That is your job to figure out before you start.
Who Should Not Use Weight Loss Injections?
The answer is not vague. There are clear groups of people who should avoid these medications based on clinical evidence and prescribing guidelines.
1. People with a Personal or Family History of Medullary Thyroid Cancer
This is a hard no. GLP-1 receptor agonists carry a black box warning for medullary thyroid carcinoma (MTC). Animal studies showed thyroid tumors at clinically relevant doses. The FDA requires this warning on all GLP-1 medications.
If you or a first-degree relative has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), these injections are contraindicated. Full stop.
2. People Who Are Pregnant or Breastfeeding
There is no safe data on GLP-1 use during pregnancy. Animal studies show fetal harm at doses similar to human therapeutic doses. The recommendation is to stop these medications at least two months before trying to conceive.
If you are breastfeeding, the drug can pass into breast milk. The risk to the infant is unknown, so the guidance is to avoid use entirely during this period.
3. People with a History of Pancreatitis
GLP-1 medications have been linked to acute pancreatitis. If you have had pancreatitis before, your pancreas is already vulnerable. Using a drug that can trigger another episode is a serious risk.
In my experience reviewing the research, the data here is not fully settled, but the prescribing guidelines are clear. A history of pancreatitis is a reason to avoid these drugs or at minimum have a very direct conversation with your doctor before starting.
4. People with Severe Gastrointestinal Disease
These injections slow gastric emptying. That is part of how they reduce appetite. But if you have gastroparesis (delayed stomach emptying) or other serious GI conditions, slowing things down further can cause real problems. Nausea, vomiting, and bowel obstruction risk all go up.
What I found in the clinical literature is that people with pre-existing GI motility issues had significantly worse side effect profiles on GLP-1 drugs compared to the general trial population.
Are Weight Loss Injections Safe for People with Diabetes?
This one is more nuanced. GLP-1 medications were originally developed for type 2 diabetes. Ozempic is still primarily prescribed as a diabetes drug. So for many people with type 2 diabetes, these injections are not just safe, they are beneficial.
The SUSTAIN and LEADER trials showed semaglutide reduced cardiovascular events in people with type 2 diabetes. That is a meaningful benefit beyond just blood sugar control.
But there are exceptions. People with type 1 diabetes need careful monitoring because the mechanism works differently without functional beta cells. And people on insulin or sulfonylureas face a real hypoglycemia risk when adding a GLP-1 drug. Blood sugar can drop too low, too fast.
The answer is that diabetes alone does not disqualify you. But your specific diabetes management plan, your medications, and your kidney function all matter. This needs a proper medical review, not a quick online prescription. Understanding potential drug interactions is essential before starting any weight loss medication.
Can People with Heart Conditions Use Weight Loss Injections?
For most people with heart disease, the data actually supports use. The SELECT trial published in 2023 showed semaglutide reduced major cardiovascular events by 20% in people with obesity and established cardiovascular disease. That is a significant finding.
So having a heart condition is not a reason to avoid these drugs. In many cases it is a reason to consider them.
The exception is people with a history of severe heart failure or those with unstable cardiac conditions. The cardiac stress that come with these medications can stress an already compromised heart. Anyone with serious cardiac history needs cardiology input before starting.
Resting heart rate also tends to increase slightly on GLP-1 medications. For most people this is not a problem. For someone with certain arrhythmias, it is worth discussing with a cardiologist first.
Are Weight Loss Injections Suitable for Teenagers or Children?
The FDA approved semaglutide (Wegovy) for adolescents aged 12 and older with obesity in 2022. That approval was based on the STEP TEENS trial, which showed meaningful weight reduction with an acceptable safety profile in that age group.
But this does not mean every teenager should use it. The approval is specifically for adolescents with a BMI at or above the 95th percentile for their age and sex. It is not for general weight management in young people.
Children under 12 have no approved indication for these drugs. The long-term effects on growth, bone density, and hormonal development in young people are not fully understood yet. What I saw in the available data is that short-term outcomes look reasonable, but we simply do not have 10 or 20 year follow-up data for this age group.
For teenagers, the decision needs to involve a pediatric specialist, not just a general practitioner. And it should never replace building real nutrition and movement habits. The injection is not a substitute for learning how to eat and train well.
Should People with a History of Eating Disorders Use Weight Loss Injections?
This is one of the most important questions and one of the least discussed.
The honest answer is that people with a history of anorexia, bulimia, or binge eating disorder need to approach these medications with serious caution, and in many cases should avoid them entirely.
Here is why. GLP-1 drugs suppress appetite strongly. For someone recovering from restrictive eating, that suppression can reinforce disordered patterns. The drug makes it easier to not eat, which feels like success but can be a relapse trigger.
For binge eating disorder, the picture is more complex. Some research suggests GLP-1 drugs reduce binge episodes by acting on reward pathways in the brain. But the data is early and the risk of using a weight-focused intervention in someone with a complex relationship with food is real.
What I found consistently in the clinical literature is that eating disorder history is listed as a reason for careful psychological screening before prescribing, not an automatic exclusion, but a serious flag that requires mental health input alongside medical oversight.
If you have a history of disordered eating, a weight loss injection prescribed without psychological support is not a complete treatment plan.
Can People with Kidney or Liver Disease Use Weight Loss Injections?
Kidney disease requires careful consideration. Semaglutide itself is not primarily cleared by the kidneys, so mild to moderate chronic kidney disease (CKD) is not an automatic contraindication. The FLOW trial actually showed semaglutide slowed kidney disease progression in people with type 2 diabetes and CKD. That is a positive finding.
But severe kidney disease (eGFR below 15) or end-stage renal disease is a different situation. Dehydration from nausea and vomiting, which are common side effects, can seriously worsen kidney function in someone already at the edge. Dose adjustments and close monitoring are essential.
For liver disease, the data is more limited. Non-alcoholic fatty liver disease (NAFLD) actually improves on GLP-1 therapy in most studies. But severe liver impairment affects how drugs are metabolised and cleared. People with cirrhosis or severe hepatic impairment were largely excluded from the major trials, so the safety data simply does not exist for that group.
The practical answer is that mild to moderate kidney or liver issues do not automatically rule out these medications, but severe impairment in either organ requires specialist input and likely rules them out until more data exists.
FAQ
Can I use weight loss injections if I take antidepressants?
There is no direct contraindication between GLP-1 drugs and most antidepressants. But some antidepressants cause weight gain, and the interaction between appetite suppression and mood regulation is worth monitoring. Tell your prescribing doctor about all medications you take.
Do weight loss injections affect fertility?
There is some evidence that weight loss itself improves fertility in people with obesity-related hormonal issues like PCOS. But GLP-1 drugs are not approved for use during pregnancy attempts or pregnancy. Stop the medication before trying to conceive.
Can older adults use weight loss injections?
Age alone is not a contraindication. But older adults are more likely to have the conditions that do matter, kidney function decline, cardiac history, polypharmacy. A thorough medical review is more important, not less, as age increases.
What happens if someone who should not use these injections takes them anyway?
The risks depend on the specific contraindication. For someone with a thyroid cancer history, the concern is tumour promotion. For someone with pancreatitis history, it is acute pancreatic inflammation. For someone with severe kidney disease, it is acute kidney injury from dehydration. These are not theoretical risks. They are documented in post-market surveillance data.
The Bottom Line on Who Should Not Use Weight Loss Injections
The people who should not use weight loss injections include those with a personal or family history of medullary thyroid cancer, MEN 2 syndrome, current pregnancy or breastfeeding, a history of pancreatitis, severe gastroparesis, and in many cases, active or recent eating disorders without psychological support.
People with diabetes, heart conditions, or kidney and liver disease are not automatically excluded, but they need proper medical evaluation, not a telehealth script written in five minutes.
The drug works by changing how your body processes food and regulates hunger. That is a powerful mechanism. It deserves a proper assessment of your full health picture before you start.
If you want to understand whether your health profile makes you a good candidate, working with a qualified health professional who looks at your whole situation, not just your weight, is the right move. An online personal trainer who understands metabolic health can also help you build the nutrition and training foundation that makes any medical intervention more effective and more sustainable long term.
